Client Success Archives

Iodine Software Announces Brad Wensel Joining Company as Chief Customer Officer

Wensel will guide the customer experience across Iodine’s suite of solutions, including 2023’s “Best in KLAS CDI Software”

AUSTIN, Tex. – May 1, 2003 – Iodine Software, a pioneer in healthcare AI technology, today announced that Brad Wensel has joined the company as Chief Customer Officer. Wensel brings a track record of success as an executive leader with deep experience building cross functional customer-centric teams. In this newly created role, Wensel will be responsible for guiding the Iodine customer experience with oversight of customer success, operations, services and support teams.

“I am thrilled to be joining Iodine Software as the company’s first Chief Customer Officer leading the customer-facing and operation teams.” said Wensel, “For organizations to continue to disrupt and innovate as Iodine has done, it takes a commitment to customer success – putting the customer in the center of all we do – so that we can deliver improved business outcomes. My first priority will be to align our teams to facilitate a connected end-to-end customer journey that accelerates customer time-to-value”

With significant experience building and overseeing customer success teams that deliver outstanding business results, Wensel joins Iodine from Amazon Web Services (AWS), where he worked as Head of Partners and Commercial Excellence, overseeing Partner Engagement and Business Strategy teams supporting U.S. health systems and cloud technology adoption and business transformation initiatives.

“At Iodine, we recognize that our success is directly tied to our customers’ success. The addition of Brad as our new Chief Customer Officer signals a renewed commitment to delivering exceptional customer experiences” said Iodine Software Co-founder and CEO William Chan, who was named a winner of EY’s Entrepreneur Of The Year® 2022 Central South Award, “He plays a critical role in this effort by leading the development of innovative customer service strategies, driving improvements in our Software-as-a-Service, and championing a culture of customer-centricity throughout the organization. I am confident that Brad will deliver on this promise of significant positive impact to our customers for years to come.”

Prior to AWS, Wensel was Executive Vice President and Chief Customer Officer at Healthgrades, where he worked with the nation’s leading health systems to transform their customer acquisition, marketing and engagement strategies. In his role, Brad oversaw onboarding, support professional services, customer success and growth teams. Previously, he held several leadership positions at Catapult Marketing, subsidiary of Epsilon and News America Marketing, A News Corporation Company.

Wensel holds an MBA from Purdue University Krannert School of Management, and a BS in Business Administration from Duquesne University.

Iodine Software counts more than 900 hospitals and health systems as customers. Its platform includes the top clinical documentation improvement (CDI) software, which has been recognized as the Best In KLAS CDI solution two years running. In 2021, the company completed two key acquisitions, including CDI software company ChartWise Medical Systems and physician engagement platform Artifact Health.

About Iodine Software

Iodine is an enterprise AI company that is championing a radical rethink of how to create value for healthcare professionals, leaders, and their organizations: automating complex clinical tasks, generating insights and empowering intelligent care. Iodine’s powerful predictive engine complements the skills and judgment of healthcare professionals by interpreting raw clinical data to generate real-time, highly focused, predictive insights that clinicians and hospital administrators can leverage to dramatically augment the management of care delivery – facilitating critical decisions, scaling clinical workforces through automation, and improving the financial position of health systems. For more information, please visit iodinesoftware.com.

Unlocking the Power of Concurrent

Key Takeaways:

Concurrent can be a disruptive technology requiring some key shifts in thinking and processes to unlock its full potential
Auto-assignment allows for complex cases to be distributed evenly across a team and for better coverage when there’s a gap in staffing
When setting quiet periods, shoot for a time range that’s appropriate 80% of the time
When artificial intelligence and machine learning are leveraged to provide a prioritized list of cases for review, priority review rate is a more important metric than number of initial reviews and re-reviews
In healthcare’s ever changing landscape, it’s key to periodically reassess your configurations to ensure they’re still best fit

Iodine Intelligence tackles a new challenge in healthcare’s mid-revenue cycle every month, shedding light on problems and solutions and sharing valuable insights from industry experts. Listen to Episode 10: Unlocking the Power of Concurrent to learn more.

Concurrent is Iodine’s flagship software, and it leverages artificial intelligence and machine learning to prioritizes cases for CDI teams to review concurrently before patients are discharged based on misalignment between the clinical evidence and existing documentation.

In this month’s episode we sat down with Iodine’s Client Services Operations Manager, Justin Gerardot, and Iodine’s Clinical Product Consultant Manager, Diana O’Connor, for some tips and tricks for our users to get the most out of Concurrent. Concurrent, and it’s prioritization, can be referred to as a “disruptive” technology, and there are some key shifts in thinking and processes required to unlocking the full potential and return of Concurrent.

1. Auto-Assignment

Concurrent distributes cases to CDS’s for review using auto-assignment, which can be a shift for CDI teams who are used to cases being distributed by location or service line.

Iodine advocates for a “generalist” rather than a “specialist” approach. Some service lines are, by their nature, more complex than others, and auto-assignment allows for those complex cases to be distributed evenly across a team. It also helps when a CDS is on vacation or there’s a gap in coverage: everyone is able to cover and review those cases.

2. Quiet Periods

A Quiet Period is the amount of time a case must “incubate” before it can be considered for auto-assignment. It can be a delicate balance walking the line between a quiet period that is too short, and CDS’s receive cases for review with very little information, and a quiet period that is too long, and the patient is discharged before the case gets a chance to be prioritized and reviewed.

When selecting a quiet period, Iodine recommends shooting for the 80/20 rule: 80% of the cases are prioritized at the appropriate time or within the appropriate window.

3. Metrics

Concurrent provides teams with an intuitive, prioritized work-list in order to get the right cases in front of CDS at the right time, and because of this, Iodine is not as concerned with how many initial reviews and re-reviews a CDS does on a given day or during a given week. Instead, Iodine focuses on priority review rate: how many high priority cases did you get to.

It can be difficult moving away from longstanding, traditional KPIs, especially when they’re used for projections and staffing needs. Iodine has a robust reporting platform to support these new metrics, allowing CDI teams to easily track their progress.

4. Reassess

Healthcare is an ever changing field, and as a result it can be very helpful for hospitals and healthcare providers to reassess their Iodine configurations on at least an annual basis. Changes to the size of a CDI team, adding additional service lines or payors, and software updates within Concurrent itself can all impact the way CDS interact with Concurrent. Reevaluating your configurations, especially once you have six month’s to a year’s worth data to help with your evaluation, can help ensure you’re staying at top functionality.

Interested in Being on the Show?

Iodine Software’s mission has been to change healthcare by applying our deep experience in healthcare along with the latest technologies like machine learning to improve patient care. The Iodine Intelligence podcast is always looking for leaders in the healthcare technology space to further the conversation in how technology and clinicians can work together to empower intelligent care. if that sounds like you, we want to hear from you!

The Journey to KLAS with William Chan and Tim O’Hara

Key Takeaways:

One of the biggest challenges Iodine faced was awareness – overcoming obstacles often associated with a new approach to a problem
Delivering both a product that people want to use and fulfilling the promises you make in the product are key
Be hungry for feedback, and be humble enough to accept both positive and negative feedback in order to stay responsive to the industry

Iodine Intelligence tackles a new challenge in healthcare’s mid-revenue cycle every month, shedding light on problems and solutions and sharing valuable insights from industry experts. Listen to Episode 3: Journey to KLAS with William Chan and Tim O’Hara to learn more.

KLAS is an independent, third-party organization that reviews vendor solutions and publishes an annual report of its findings. KLAS is known in the market for honest insights informed by robust research. This year, Iodine Software’s AwareCDI Suite was named #1 Best in KLAS in Clinical Documentation Integrity software. This award represents the culmination of years of hardwork and dedication, as previously Iodine was a top performer in the annual KLAS Clinical Documentation Improvement reports for three consecutive years.

Whereas once Iodine was seen as a narrow part of the CDI workflow, the team has worked diligently to develop trust in the application and build out functionality to deliver a comprehensive CDI platform. Being named Best in Klas serves not only as validation that AwareCDI is a product people find value in, but is also a reflection of Iodine’s exceptional team, and their work to provide superior post-sales service. In the words of William Chan, CEO and co-founder, “Because it’s so all encompassing, a best in KLAS award is really a culmination of a lot of work and a lot of people coming together.”

Tim O’Hara, Vice President of Client Experience, wanted to be sure to thank all those who made this achievement possible, saying “First of all, how incredibly humble I am, and we all are, to receive this award, and incredibly grateful for all our employees and customers, because we couldn’t do it without them.”

“It’s not enough for us to think we have a great product with great service, that needs to be validated and affirmed by healthcare professionals who hold us to a very high standard, as they should.”
– Tim O’Hara, Vice President Client Experience

Iodine has a robust team of people surrounding, and providing front-line support, to end users, including everything from Client Success Managers and clinical experts supporting organizations strategic priorities, to a technical support team available to answer questions, to customized training and support. Staff work with clients to establish key goals and how they’ll be measured up-front, allowing for transparent conversations on KPIs and enabling Iodine to achieve one of its founding principles: delivering on commitments. William believes delivering both a product that people want to us, and on the promises you make in the product are key, “We have always done our utmost, and worked our hardest, to make sure that we deliver on as many promises as we have made. I think that’s what you build your product and your company on, that’s what takes you on that trajectory towards best in KLAS.”

KLAS’s annual report provides a unique opportunity for organizations to garner additional feedback from clients. Reviews are anonymous, which can result in more candid responses, and KLAS interviews go deeper than your average NPS survey, asking things like “does this vendor keep their promises” and “are they part of your long term plans. William calls KLAS’s drive to understanding the true insights that come out of customers an obsession, and interestingly believes that embracing a similar level of obsession to be a key trait moving forward. “We need to obsess over getting behind the scenes, peeling back the layer of the onion, to know where we’ve messed up, where we haven’t done the right things, and it’s that obsession with wanting to hit the mark with the customer that is going to allow us to continue to be best in KLAS. That’s the marching orders I give to the organization.”

Interested in Being on the Show?

Iodine Software Recognized as 2022 Best in KLAS CDI Software

AUSTIN, TX – February 8, 2022 – Iodine Software has been named the market leader for CDI Software by KLAS Research in their 2022 Best in KLAS: Software and Services Report. Iodine ranked #1 with a score of 91.2, and this achievement follows AwareCDI™ receiving the top overall performance score in the 2021 KLAS Clinical Documentation Improvement (CDI) Report. In 2021 Iodine Software acquired Chartwise, who was also a top performer in the 2022 KLAS report with a score of 89.2.

The Best in KLAS report recognizes software and services companies who excel at helping healthcare professionals improve patient care. The report noted that 95% of respondents answered “yes,” both Iodine AwareCDI and Chartwise “avoid charging for every little thing” and AwareCDI was “part of long-term plans”. All rankings are a direct result of the feedback of thousands of providers over the last year. “This award reflects our commitment to delivering the most powerful, predictive tools as well as exceptional service and support to every client, working hard to be responsive, timely and proactive to our clients’ unique needs, said William Chan, CEO and co-founder of Iodine. “This Best in KLAS award is especially meaningful because it reflects the positive experiences of our clients.”

Iodine’s AwareCDI solution empowers organizations to scale their most precious and limited resources, their clinical talent, through automation of clinical work that otherwise would require highly trained and specialized staff to complete. Clients report higher productivity and job satisfaction for CDI teams and physicians, complete and accurate documentation, and capturing more earned revenue. The Iodine AwareCDI Suite helps 550+ hospitals to collectively recognize $1.5 billion¹ in additional appropriate reimbursement annually.

According to KLAS Research President Adam Gale, “The Best in KLAS report and the awards it contains set the standard of excellence for software and services firms. The Best in KLAS award serves as a signal to provider and payer organizations that they should expect excellence from the winning vendors.”

To download the full 2022 KLAS Clinical Documentation Improvement Report, visit : https://klasresearch.com/report/2022-best-in-klas-awards-software-and-professional-services/2770

KLAS Research will honor Iodine and the other segment winners for 2022 in a ceremony held at HIMSS March 14th.

About Iodine Software:
Iodine is an enterprise AI company that is championing a radical rethink of how to create value for healthcare professionals, leaders, and their organizations: automating complex clinical tasks, generating insights and empowering intelligent care. Iodine’s powerful predictive engine complements the skills and judgment of healthcare professionals by interpreting raw clinical data to generate real-time, highly focused, predictive insights that clinicians and hospital administrators can leverage to dramatically augment the management of care delivery – facilitating critical decisions, scaling clinical workforces through automation, and improving the financial position of health systems. For more information, please visit iodinesoftware.com.

About KLAS Research:
KLAS has been providing accurate, honest, and impartial insights for the healthcare IT (HIT) industry since 1996. The KLAS mission is to improve the world’s healthcare by amplifying the voice of providers and payers. The scope of our research is constantly expanding to best fit market needs as technology becomes increasingly sophisticated. KLAS finds the hard-to-get HIT data by building strong relationships with our payer and provider friends in the industry. Learn more at klasresearch.com

_{1. Figures are based on a $6,000 modeled base rate and actual measured MCC capture performance from the 2019 Iodine Performance Cohort Analysis of 339 facilities that compared measured MCC capture and CMI impact for the Iodine usage period 9/1/2018-8/31/2019 against pre-Iodine baseline performance.}

Iodine Software

Insights Category: Client Success

Iodine Software Announces Brad Wensel Joining Company as Chief Customer Officer